Physician profile
Delaney Crouch
NPI 1063244010
$1,144.36
in general payments reported to CMS, 2019-2025
21 companies · $963 in 2025
The $963 reported for 2025 was more than what 84% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $182 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.37 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $265.71 | 2024-2025 | Lynparza, Tagrisso, Airsupra |
| Sobi, INC | $123.32 | 2025 | |
| Intera Oncology, INC | $88.37 | 2025 | Intera |
| Novartis Pharmaceuticals Corporation | $75.10 | 2024-2025 | |
| Pfizer INC. | $64.35 | 2025 | |
| Glaxosmithkline, LLC. | $60.47 | 2024-2025 | Ojjaara, Shingrix, Arexvy |
| Sumitomo Pharma America, INC. | $49.52 | 2025 | Gemtesa |
| Genzyme Corporation | $48.19 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $46.11 | 2025 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $42.20 | 2025 | Darzalex, Tecvayli, Talvey |
| Astellas Pharma US INC | $40.36 | 2025 | Vyloy, Padcev |
| Alexion Pharmaceuticals, INC. | $39.27 | 2024-2025 | Ultomiris |
| Lilly USA, LLC | $34.96 | 2024-2025 | Verzenio, Jaypirca, Retevmo |
| Abbvie INC. | $28.19 | 2025 | |
| Daiichi Sankyo INC. | $26.53 | 2025 | Enhertu |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Geron Corporation | $24.99 | 2025 | Rytelo |
| Celgene Corporation | $21.53 | 2025 | Reblozyl |
| Puma Biotechnology, INC. | $18.51 | 2025 | |
| Axsome Therapeutics, INC. | $16.75 | 2025 | Symbravo |
| Immunocore Limited | $15.14 | 2025 | Kimmtrak |
| Genentech USA, INC. | $14.79 | 2025 | Tecentriq Hybreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delaney Crouch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.